• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Introduction to 1-(4-Pyridinyl)-1-ethanone Oxime (CAS No. 107445-21-6) and Its Emerging Applications in Chemical Biology

1-(4-Pyridinyl)-1-ethanone oxime, identified by the chemical abstracts service number 107445-21-6, is a heterocyclic compound that has garnered significant attention in the field of chemical biology due to its unique structural and functional properties. This compound belongs to the class of pyridine derivatives, which are widely recognized for their diverse pharmacological activities. The presence of an oxime functional group in its molecular structure imparts distinct reactivity, making it a valuable scaffold for the development of novel bioactive molecules.

The chemical structure of 1-(4-pyridinyl)-1-ethanone oxime consists of a pyridine ring substituted at the 4-position with an ethanone oxime moiety. This arrangement creates a molecule with potential interactions with biological targets, including enzymes and receptors, which are critical for various physiological processes. The oxime group is particularly noteworthy, as it can participate in coordination with metal ions and form hydrogen bonds, enhancing the compound's binding affinity to biological macromolecules.

In recent years, there has been a surge in research focused on exploiting the structural features of pyridine derivatives for therapeutic applications. The oxime functional group, in particular, has been extensively studied for its ability to modulate enzyme activity and receptor binding. For instance, studies have demonstrated that oximes can serve as potent inhibitors of acetylcholinesterase, a key enzyme involved in neurodegenerative diseases such as Alzheimer's disease. 1-(4-Pyridinyl)-1-ethanone oxime has been explored as a potential lead compound in this context, showing promise in preclinical studies for its ability to cross the blood-brain barrier and exert neuroprotective effects.

Moreover, the pyridine ring in 1-(4-pyridinyl)-1-ethanone oxime provides a versatile platform for further chemical modification, enabling the synthesis of analogs with tailored biological activities. Researchers have leveraged this flexibility to develop compounds with enhanced selectivity and reduced toxicity. For example, structural modifications aimed at optimizing the electronic properties of the pyridine ring have led to derivatives with improved binding affinity to specific biological targets. These advancements highlight the compound's potential as a building block for drug discovery efforts.

The synthesis of 1-(4-pyridinyl)-1-ethanone oxime involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. The process typically begins with the condensation of 4-pyridinemethanol with hydroxylamine hydrochloride under acidic conditions, followed by purification steps such as recrystallization or column chromatography. Recent innovations in synthetic methodologies have improved the efficiency of these processes, making it more feasible to produce larger quantities of the compound for research purposes.

One of the most compelling aspects of 1-(4-pyridinyl)-1-ethanone oxime is its potential application in medicinal chemistry beyond neurodegenerative diseases. Emerging research suggests that this compound may have antimicrobial properties, making it a candidate for developing novel antibiotics or antifungal agents. The oxime group's ability to interact with bacterial enzymes has been hypothesized to disrupt essential metabolic pathways, leading to cell death. Preliminary studies have shown promising results when tested against certain resistant strains of bacteria, indicating that further investigation is warranted.

Additionally, 1-(4-pyridinyl)-1-ethanone oxime has been investigated for its role in modulating inflammatory responses. Chronic inflammation is a hallmark of numerous diseases, including cardiovascular disorders and autoimmune conditions. The compound's interaction with inflammatory signaling pathways has been explored in vitro and in vivo models, revealing potential anti-inflammatory effects. These findings suggest that 1-(4-pyridinyl)-1-ethanone oxime could be developed into a therapeutic agent for managing inflammatory diseases.

The growing interest in 1-(4-pyridinyl)-1-ethanone oxime has also spurred advancements in computational chemistry and drug design methodologies. Molecular modeling techniques have been employed to predict how this compound interacts with biological targets at an atomic level. These simulations have helped researchers identify key structural features responsible for its bioactivity and guide the design of more potent derivatives. Such computational approaches are increasingly integral to modern drug discovery pipelines, accelerating the development of novel therapeutics.

In conclusion, 1-(4-pyridinyl)-1-ethanone oxime (CAS No. 107445-21-6) represents a promising candidate for further exploration in chemical biology and medicinal chemistry. Its unique structural features and demonstrated biological activities make it a valuable scaffold for developing new drugs targeting neurodegenerative diseases, infections, and inflammation. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in future therapeutic strategies.

• 1194-99-6(1-(4-pyridyl)ethanone oxime)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)